AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17044452 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular vaccination (IM group)
Number of subjects: 51
Study 12830437 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Hemodialysis (n = 11)
Number of subjects: 23
Study 12830437 — intervention group
Group type: COMPARATOR
Intervention: Nocturnal Hemodialysis (n = 12)
Number of subjects: 23
Study 12830437 — intervention group
Group type: COMPARATOR
Intervention: Conventional Thrice-Weekly Hemodialysis (Control)
Number of subjects: 23
Study 12830437 — intervention group
Group type: EXPERIMENTAL
Intervention: Quotidian HD patients using catheters
Number of subjects: 23
Study 12830437 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with AV fistulae
Number of subjects: 23
Study 12830437 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 23
Study 10952796 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT + LCT
Number of subjects: 36
Study 10952796 — intervention group
Group type: COMPARATOR
Intervention: LCT alone
Number of subjects: 36
Study 9417514 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg/d)
Number of subjects: 50
Study 9417514 — intervention group
Group type: COMPARATOR
Intervention: Control group (historical control without specific prophylaxis)
Number of subjects: 50
Study 1583246 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 204,219 (40 mg)
Number of subjects: 15
Study 1583246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 28926197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery followed by pars plana vitrectomy (CAT group)
Number of subjects: 62
Study 28926197 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy followed by cataract surgery (VIT group)
Number of subjects: 62
Study 28926197 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined phacoemulsification‐vitrectomy (COMBI group)
Number of subjects: 62
Study 28926197 — intervention group
Group type: COMPARATOR
Intervention: Cataract surgery (CAT group)
Number of subjects: 62
Study 26842261 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic exposure to alcohol advertising during sports events
Number of subjects: 108
Study 26842261 — intervention group
Group type: COMPARATOR
Intervention: No advertising exposure
Number of subjects: 108
Study 26608342 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-alcohol antimicrobial mouth rinse containing cetylpyridinium chloride and oral health education
Number of subjects: 468
Study 26608342 — intervention group
Group type: COMPARATOR
Intervention: Control group received a package of toothbrush and paste, plus oral hygiene education
Number of subjects: 468
Study 23885612 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture with penetration needling method (group A)
Number of subjects: 160
Study 23885612 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiaji electroacupuncture (group B)
Number of subjects: 160
Study 23885612 — intervention group
Group type: COMPARATOR
Intervention: Jing fukang granule (group C)
Number of subjects: 160
Study 20568432 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (needles at Zusanli (ST 36), Zhongwan (CV 12), Weishu (BL 21), Neiguan (PC 6), once a day)
Number of subjects: 61
Study 20568432 — intervention group
Group type: COMPARATOR
Intervention: Medication treatment (20 mg Omeprazole, once a day)
Number of subjects: 61
Study 18489927 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (n = 50)
Number of subjects: 101
Study 18489927 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean-style diet (n = 51)
Number of subjects: 101
Study 18489927 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined dietary intervention (n = 101)
Number of subjects: 101
Study 18489927 — intervention group
Group type: COMPARATOR
Intervention: Usual-care controls (n = 101)
Number of subjects: 101
Study 16519864 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study 16519864 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 0
Study 16519864 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and Atropine
Number of subjects: 0
Study 16519864 — intervention group
Group type: COMPARATOR
Intervention: PDM methodology
Number of subjects: 0
Study 12930517 — intervention group
Group type: EXPERIMENTAL
Intervention: L-E-GTF
Number of subjects: 12
Study 12930517 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble E-GTF
Number of subjects: 12
Study 12930517 — intervention group
Group type: COMPARATOR
Intervention: Both groups (L-E-GTF and Soluble E-GTF)
Number of subjects: 12
Study 10636351 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen deposition in men younger than 45 years
Number of subjects: 116
Study 10636351 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen deposition in men older than 45 years
Number of subjects: 116
Study 10636351 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen deposition in women younger than 45 years
Number of subjects: 116
Study 10636351 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen deposition in women older than 45 years
Number of subjects: 116
Study 10636351 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of collagen deposition between men and women
Number of subjects: 116
Study 15321259 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nalmefene 0.25 micro.kg(‐1) every 12 h x 2
Number of subjects: 80
Study 15321259 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nalmefene 0.5 microg.kg(‐1) every 12 h x 2
Number of subjects: 80
Study 15321259 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone infusion 48 microg.h(‐1) (1.2 microg.ml(‐1))
Number of subjects: 80
Study 15321259 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 80
Study 1738553 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic eardrops administered to right ears intraoperatively and for 3 days post-surgery
Number of subjects: 200
Study 1738553 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic eardrops (control) administered to left ears
Number of subjects: 200
Study 4006253 — intervention group
Group type: EXPERIMENTAL
Intervention: slow release Nifedipine (srN) 20 mg b.d.
Number of subjects: 11
Study 4006253 — intervention group
Group type: EXPERIMENTAL
Intervention: slow release Nifedipine (srN) 20 mg b.d. plus Acebutolol (A) 400 mg
Number of subjects: 11
Study 4006253 — intervention group
Group type: COMPARATOR
Intervention: placebo (P)
Number of subjects: 11
Study 30703062 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg
Number of subjects: 130
Study 30703062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 29635145 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended letrozole (2.5 or 5 years)
Number of subjects: 0
Study 29635145 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment discontinuation
Number of subjects: 0
Study 27508126 — intervention group
Group type: EXPERIMENTAL
Intervention: Septoplasty with partial inferior turbinectomy (Group A)
Number of subjects: 60
Study 27508126 — intervention group
Group type: COMPARATOR
Intervention: Septoplasty alone (Group B)
Number of subjects: 60
Study 27508126 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Group A and Group B
Number of subjects: 60
Study 25403215 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstract with spin
Number of subjects: 300
Study 25403215 — intervention group
Group type: COMPARATOR
Intervention: Abstract without spin
Number of subjects: 300
Study 21745326 — intervention group
Group type: EXPERIMENTAL
Intervention: Early loading (1 week after surgery)
Number of subjects: 26
Study 21745326 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading (3 months after surgery)
Number of subjects: 26
Study 20205171 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprathreshold gustatory stimuli
Number of subjects: 34
Study 18812115 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mL preservative‐free lidocaine hydrochloride 1% injected in the capsular bag during hydrodissection
Number of subjects: 120
Study 18812115 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (BSS) (control group)
Number of subjects: 120
Study 15987916 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil
Number of subjects: 185
Study 15987916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 12913083 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (PPC) with 5-FU (320 mg/m²/day for 5 days) and postoperative chemotherapy with MMC (6 mg/m²) and oral 5-FU (200 mg/day for 6 months)
Number of subjects: 1355
Study 12913083 — intervention group
Group type: COMPARATOR
Intervention: Postoperative chemotherapy (PC) with MMC (6 mg/m²) and oral 5-FU (200 mg/day for 6 months)
Number of subjects: 1355
Study 12913083 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (PPC)
Number of subjects: 1355
Study 12913083 — intervention group
Group type: COMPARATOR
Intervention: Postoperative chemotherapy (PC)
Number of subjects: 1355
Study 10337848 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention (C-B), 8 weeks
Number of subjects: 65
Study 10337848 — intervention group
Group type: COMPARATOR
Intervention: Attention-only (A-O) placebo telephone calls, 8 weeks
Number of subjects: 65
Study 7572702 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary calcium intake of 1768 mg/d (44 mmol/d)
Number of subjects: 124
Study 7572702 — intervention group
Group type: EXPERIMENTAL
Intervention: Halving daily sodium excretion
Number of subjects: 124
Study 7572702 — intervention group
Group type: COMPARATOR
Intervention: Urinary sodium excretion
Number of subjects: 124
Study 7572702 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary calcium intake and urine sodium excretion
Number of subjects: 124
Study 1951503 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg methylcellulose gel
Number of subjects: 40
Study 1951503 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg controlled-release pessary
Number of subjects: 40
Study 6216050 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide
Number of subjects: 60
Study 31261231 — intervention group
Group type: EXPERIMENTAL
Intervention: None (observational study)
Number of subjects: 88
Study 28118733 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulax (309.21±62.48U)
Number of subjects: 187
Study 28118733 — intervention group
Group type: COMPARATOR
Intervention: Botox (312.64±49.99U)
Number of subjects: 187
Study 28118733 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Botulax and Botox
Number of subjects: 187
Study 25720622 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffold (BVS)
Number of subjects: 240
Study 25720622 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES) and Biolimus-eluting stents (BES)
Number of subjects: 240
Study 25720622 — intervention group
Group type: EXPERIMENTAL
Intervention: BVS
Number of subjects: 240
Study 25720622 — intervention group
Group type: COMPARATOR
Intervention: EES/BES
Number of subjects: 240
Study 24311014 — intervention group
Group type: COMPARATOR
Intervention: T2 MRI
Number of subjects: 52
Study 24311014 — intervention group
Group type: EXPERIMENTAL
Intervention: T2 + DWI MRI
Number of subjects: 52
Study 24311014 — intervention group
Group type: EXPERIMENTAL
Intervention: T2 + Gadolinium MRI
Number of subjects: 52
Study 24311014 — intervention group
Group type: EXPERIMENTAL
Intervention: T2 + DWI MRI vs T2 + Gadolinium MRI
Number of subjects: 52
Study 23151703 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglycolic acid suture
Number of subjects: 50
Study 23151703 — intervention group
Group type: COMPARATOR
Intervention: Black silk suture
Number of subjects: 50
Study 19684236 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict glucose control with predominantly meal related insulin using subcutaneous insulin
Number of subjects: 33
Study 19684236 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict glucose control with predominantly basal insulin using intravenous insulin
Number of subjects: 33
Study 19684236 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucose lowering therapy
Number of subjects: 33
Study 19684236 — intervention group
Group type: COMPARATOR
Intervention: Hyperglycaemic control group
Number of subjects: 33
Study 19684236 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal related insulin group
Number of subjects: 33
Study 19684236 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin group
Number of subjects: 33
Study 17454716 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone and nicotine patch
Number of subjects: 385
Study 15631893 — intervention group
Group type: EXPERIMENTAL
Intervention: Motion extrapolation algorithm based on average velocity with adjustments for recent observations
Number of subjects: 126
Study 12115173 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg)
Number of subjects: 632
Study 12115173 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 632
Study 10194050 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-adjusted target
Number of subjects: 94
Study 10194050 — intervention group
Group type: COMPARATOR
Intervention: Poorly adjusted target
Number of subjects: 94
Study 10194050 — intervention group
Group type: COMPARATOR
Intervention: Unspecified psychological and physical health status
Number of subjects: 94
Study 7583815 — intervention group
Group type: EXPERIMENTAL
Intervention: Women born in the late 1920s and early 1930s
Number of subjects: 293
Study 7583815 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with traditional lifestyles
Number of subjects: 293
Study 7583815 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with competing roles such as employment
Number of subjects: 293
Study 7583815 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analyses by cohort and educational level
Number of subjects: 293
Study 2389686 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 65
Study 2389686 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 65
Study 7195723 — intervention group
Group type: EXPERIMENTAL
Intervention: Eupatorium perfoliatum D2
Number of subjects: 53
Study 7195723 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 53
Study 31937442 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping in addition to flurbiprofen 200 mg/day
Number of subjects: 30
Study 31937442 — intervention group
Group type: COMPARATOR
Intervention: Flurbiprofen 200 mg/day (Control)
Number of subjects: 30
Study 29644383 — intervention group
Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for vaginal hysterectomy (VH)
Number of subjects: 46
Study 29644383 — intervention group
Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for anterior repair (AR)
Number of subjects: 46
Study 29644383 — intervention group
Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for posterior repair (PR)
Number of subjects: 46
Study 29644383 — intervention group
Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for vaginal hysterectomy (VH) for residents who had never performed VH
Number of subjects: 46
Study 29644383 — intervention group
Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for posterior repair (PR) for residents who had never performed PR
Number of subjects: 46
Study 29644383 — intervention group
Group type: EXPERIMENTAL
Intervention: Competency-based educational modules for first and second year residents
Number of subjects: 46
Study 29644383 — intervention group
Group type: COMPARATOR
Intervention: Self-directed learning (control)
Number of subjects: 46
Study 27623523 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft tissue techniques
Number of subjects: 97
Study 27623523 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural mobilization techniques
Number of subjects: 97
Study 27623523 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of soft tissue and neural mobilization techniques
Number of subjects: 97
Study 27623523 — intervention group
Group type: COMPARATOR
Intervention: Placebo superficial massage
Number of subjects: 97
Study 25826649 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT) administration prior to exposure therapy
Number of subjects: 23
Study 25826649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 23565674 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of chronic disease prevention and management (CDPM) services into primary health care
Number of subjects: 489
Study 21852519 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle intervention (5-day intervention)
Number of subjects: 0
Study 21852519 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle intervention
Number of subjects: 0
Study 21852519 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 19184209 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 18
Study 19184209 — intervention group
Group type: COMPARATOR
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 18
Study 17426195 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone infusion (1 mg/kg/d)
Number of subjects: 91
Study 15142301 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual trials-to-criterion tasks with varying numbers of pre-exposure
Number of subjects: 0
Study 15142301 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory trials-to-criterion tasks with varying numbers of pre-exposure
Number of subjects: 0
Study 15142301 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual trials-to-criterion tasks with very low numbers of pre-exposure in high positive-schizotypes
Number of subjects: 0
Study 15142301 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual trials-to-criterion tasks with very low numbers of pre-exposure in low positive-schizotypes
Number of subjects: 0
Study 10871565 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-energy or low-energy diet for 3 months followed by a weight-maintenance diet for up to 2 years
Number of subjects: 16
Study 9380299 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% natural vaginal progesterone
Number of subjects: 60
Study 9380299 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 1610632 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. fluid 1000 ml
Number of subjects: 45
Study 1610632 — intervention group
Group type: EXPERIMENTAL
Intervention: ephedrine 24 mg
Number of subjects: 45
Study 1610632 — intervention group
Group type: EXPERIMENTAL
Intervention: methoxamine 4 mg
Number of subjects: 45
Study 1610632 — intervention group
Group type: COMPARATOR
Intervention: fluid preloading
Number of subjects: 45
Study 6380281 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (2.5 or 5 mg) + Ibuprofen (600 mg)
Number of subjects: 28
Study 6380281 — intervention group
Group type: COMPARATOR
Intervention: Methadone alone
Number of subjects: 28
Study 31101688 — intervention group
Group type: EXPERIMENTAL
Intervention: Neo‐adjuvant chemotherapy (three cycles of platinum/paclitaxel chemotherapy)
Number of subjects: 90
Study 30140094 — intervention group
Group type: EXPERIMENTAL
Intervention: Crizotinib
Number of subjects: 0
Study 26340471 — intervention group
Group type: EXPERIMENTAL
Intervention: Training mask at 9,000 ft (9K)
Number of subjects: 10
Study 26340471 — intervention group
Group type: EXPERIMENTAL
Intervention: Training mask at 15,000 ft (15K)
Number of subjects: 10
Study 26340471 — intervention group
Group type: COMPARATOR
Intervention: Sham configuration (∼3,500 ft)
Number of subjects: 10
Study 26511879 — intervention group
Group type: EXPERIMENTAL
Intervention: Retromuscular light-weight polypropylene mesh (Parietene Light™, Covidien)
Number of subjects: 150
Study 26511879 — intervention group
Group type: COMPARATOR
Intervention: Traditional colostomy formation
Number of subjects: 150
Study 23199430 — intervention group
Group type: EXPERIMENTAL
Intervention: MTBI group
Number of subjects: 44
Study 23199430 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 20051216 — intervention group
Group type: EXPERIMENTAL
Intervention: REFLECT statement for livestock and food safety
Number of subjects: 24
Study 20051216 — intervention group
Group type: COMPARATOR
Intervention: CONSORT checklist
Number of subjects: 24
Study 18663162 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% low-fat dietary pattern with increased vegetables, fruits, and grains (n = 19,541)
Number of subjects: 48835
Study 18663162 — intervention group
Group type: COMPARATOR
Intervention: Usual-diet comparison group (n = 29,294)
Number of subjects: 48835
Study 18663162 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% low-fat dietary pattern
Number of subjects: 48835
Study 15582252 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 25mg/day plus finasteride 5mg/day (group B)
Number of subjects: 46
Study 15582252 — intervention group
Group type: COMPARATOR
Intervention: Finasteride 5mg/day alone (group A)
Number of subjects: 46
Study 12565779 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lignocaine hydrochloride gel (Instillagel)
Number of subjects: 100
Study 12565779 — intervention group
Group type: COMPARATOR
Intervention: Plain aqueous gel
Number of subjects: 100
Study 10646679 — intervention group
Group type: EXPERIMENTAL
Intervention: Ureterorenoscopy (URS)
Number of subjects: 156
Study 10646679 — intervention group
Group type: COMPARATOR
Intervention: Shockwave lithotripsy (SWL)
Number of subjects: 156
Study 8739937 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation using self-reinforced polyglycolide (SR-PGA) screws, poly-l-lactide (SR-PLLA) screw, small (SR-PGA) rods, and Kirschner-wires.
Number of subjects: 21
Study 8739937 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment followed by operation for removal of non-united fragment and reattachment of ligaments and muscles.
Number of subjects: 21
Study 8739937 — intervention group
Group type: COMPARATOR
Intervention: Primary excision of the fragment.
Number of subjects: 21
Study 1985173 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-Hydroperoxycyclophosphamide (4-HC) at 20 micrograms/mL
Number of subjects: 25
Study 1985173 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-Hydroperoxycyclophosphamide (4-HC) at 40 micrograms/mL
Number of subjects: 25